Fiza Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-01-2025
- Paid Up Capital ₹ 0.10 M
as on 04-01-2025
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -53.73%
(FY 2020)
- Profit -92.86%
(FY 2020)
- Ebitda 155.91%
(FY 2020)
- Net Worth 1.61%
(FY 2020)
- Total Assets 25.06%
(FY 2020)
About Fiza Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dushyant Dahra, Deepu Panankattil, Krishan Tandon, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100DL2010PTC199731
- Company No.
199731
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Mar 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Fiza Healthcare Private Limited offer?
Fiza Healthcare Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Malaria Medicine, Pain Relief Drugs & Pharmaceuticals, Antipyretic Medication, Cardiovascular Drugs & Medication, Antianginal Drugs.
Who are the key members and board of directors at Fiza Healthcare?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dushyant Dahra  | Director | 05-Mar-2010 | Current |
| Deepu Panankattil | Additional Director | 02-Mar-2023 | Current |
| Krishan Tandon | Director | 01-Dec-2011 | Current |
| Anil Pandey | Director | 28-Dec-2016 | Current |
Financial Performance of Fiza Healthcare.
Fiza Healthcare Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 53.73% decrease. The company also saw a substantial fall in profitability, with a 92.86% decrease in profit. The company's net worth moved up by a moderate rise of 1.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fiza Healthcare?
In 2020, Fiza Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Saba Impex Private LimitedActive 17 years 10 monthsDushyant Dahra and Krishan Tandon are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Fiza Healthcare?
Unlock and access historical data on people associated with Fiza Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fiza Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fiza Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
